Holen Sie sich die Stockscreener-App
29.75
8.02%
2.21
Handel nachbörslich:
29.75
Schlusskurs vom Vortag:
$27.54
Offen:
$27.87
24-Stunden-Volumen:
843.02K
Relative Volume:
1.73
Marktkapitalisierung:
$1.61B
Einnahmen:
$2.22M
Nettoeinkommen (Verlust:
$-40.51M
KGV:
-23.16
EPS:
-1.2847
Netto-Cashflow:
$-46.53M
1W Leistung:
+9.90%
1M Leistung:
+4.88%
6M Leistung:
+154.27%
1J Leistung:
+83.76%
1-Tages-Spanne:
$27.87
$30.60
1-Wochen-Bereich:
$25.00
$30.60
52-Wochen-Spanne:
$5.14
$33.00
Upstream Bio Inc Stock (UPB) Company Profile
Firmenname
Upstream Bio Inc
Sektor
Branche
Telefon
781-208-2466
Adresse
890 WINTER STREET, SUITE 200, WALTHAM
Vergleichen Sie UPB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
UPB
Upstream Bio Inc
|
29.75 | 1.49B | 2.22M | -40.51M | -46.53M | -1.2847 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Upstream Bio Inc Stock (UPB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-18 | Eingeleitet | Mizuho | Outperform |
| 2025-11-18 | Eingeleitet | Evercore ISI | Outperform |
| 2025-10-14 | Eingeleitet | Truist | Buy |
| 2024-11-05 | Eingeleitet | JP Morgan | Overweight |
| 2024-11-05 | Eingeleitet | Piper Sandler | Overweight |
| 2024-11-05 | Eingeleitet | TD Cowen | Buy |
| 2024-11-05 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Upstream Bio Inc Aktie (UPB) Neueste Nachrichten
Fed Watch: Is Upstream Bio Inc stock a bargain at current levelsJuly 2025 Final Week & Weekly Hot Stock Watchlists - moha.gov.vn
Is Upstream Bio Inc. stock vulnerable to regulatory risks2025 Technical Patterns & Weekly Top Gainers Alerts - ulpravda.ru
How Upstream Bio Inc. stock reacts to Fed rate cutsMarket Growth Report & Free Community Consensus Stock Picks - ulpravda.ru
Will Upstream Bio Inc. stock maintain dividend yield2025 Trading Recap & Weekly Stock Breakout Alerts - ulpravda.ru
Is Upstream Bio Inc. stock a bargain at current levelsMarket Performance Summary & Stepwise Swing Trade Plans - ulpravda.ru
Upstream Bio: Fully Priced After Recent Rally (NASDAQ:UPB) - Seeking Alpha
How Invesco Quality Municipal Income Trust stock performs after earningsMarket Sentiment Review & Technical Buy Zone Confirmations - ulpravda.ru
Will Upstream Bio Inc. stock rally after Fed decisionsTrading Volume Surges & Free High Yield Market Plays - ulpravda.ru
Upstream Bio initiated with an Outperform at LifeSci Capital - MSN
Upstream Bio (NASDAQ:UPB) Stock Price Down 6.2%What's Next? - MarketBeat
Upstream Bio to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewswire
Upstream Bio Inc Stock Price ($UPB), Quote & News - eToro
Upstream Bio initiated with an outperform at Mizuho - MSN
AI Indicators Detect Buy Opportunity in Zenith Drugs LimitedCash Flow Trends & Outstanding Investment Returns - earlytimes.in
Geopolitics Watch: How Upstream Bio Inc stock reacts to Fed rate cutsWeekly Market Report & Fast Momentum Entry Tips - moha.gov.vn
Upstream Bio (NASDAQ:UPB) Shares Down 3.4%Time to Sell? - MarketBeat
Treasury Yields: How Upstream Bio Inc stock reacts to global recession fearsBuy Signal & Reliable Breakout Forecasts - moha.gov.vn
Upstream Bio Reports Progress in Respiratory Trials - MSN
Upstream Bio (NASDAQ:UPB) Stock Price Up 4.8%Should You Buy? - MarketBeat
Upstream Bio (UPB) price target decreased by 18.03% to 51.00 - MSN
Upstream Bio (UPB): NASDAQ Biotech Index Entry Sparks the Big Rerating Debate - parameter.io
Upstream Bio, Inc.(NasdaqGS: UPB) added to NASDAQ Biotechnology Index - marketscreener.com
Upstream Bio, Inc. (UPB) Eps Diluted (Quarterly) - Zacks Investment Research
Upstream Bio, Inc. (NASDAQ:UPB) Receives $45.25 Average Price Target from Brokerages - Defense World
Can Upstream Bio Inc. stock weather global recessionPortfolio Risk Report & Accurate Entry and Exit Point Alerts - Улправда
Why retail investors favor Upstream Bio Inc. stockWeekly Risk Summary & Low Volatility Stock Suggestions - Улправда
Does Mizuho’s New Coverage of Upstream Bio (UPB) Reframe the Stock’s Risk‑Reward Narrative? - Sahm
How Upstream Bio Inc. stock reacts to global recession fearsNew Guidance & Risk Controlled Swing Alerts - DonanımHaber
Will Upstream Bio Inc. stock beat EPS estimatesEarnings Growth Summary & Risk Adjusted Swing Trade Ideas - Улправда
Upstream Bio (NASDAQ:UPB) Stock Rating Upgraded by Mizuho - MarketBeat
Would You Still Hold Upstream Bio Stock If It Fell 30%? - Trefis
Is Upstream Bio Inc. stock overvalued by current metricsTrade Analysis Summary & Weekly Sector Rotation Insights - Улправда
How Upstream Bio Inc. stock reacts to inflationary pressures2025 Sector Review & Risk Managed Investment Strategies - DonanımHaber
Will Upstream Bio Inc. stock benefit from green energy trends2025 Top Gainers & Expert-Curated Trade Recommendations - Улправда
Chipmakers Recap: Can Upstream Bio Inc. stock weather global recessionJuly 2025 Levels & Low Risk Investment Opportunities - Улправда
Upstream Bio, Inc. (NASDAQ:UPB) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Mizuho Initiates Coverage on UPB with Outperform Rating and $51 PT | UPB Stock News - GuruFocus
Mizuho initiates Upstream Bio stock with Outperform rating on asthma drug potential - Investing.com Canada
Upstream Bio initiated with an Outperform at Mizuho - TipRanks
Upstream Bio (NASDAQ:UPB) Stock Price Up 6.9%Time to Buy? - MarketBeat
Financial Analysis: Precision BioSciences (NASDAQ:DTIL) & Upstream Bio (NASDAQ:UPB) - Defense World
Bain Capital Life Sciences Investors LLC Raises Holdings in Upstream Bio, Inc. $UPB - MarketBeat
Norges Bank Acquires New Position in Upstream Bio, Inc. $UPB - MarketBeat
Can Upstream Bio Stock Hold Up When Markets Turn? - Trefis
Contrasting Upstream Bio (UPB) & The Competition - Defense World
Geode Capital Management LLC Buys 235,958 Shares of Upstream Bio, Inc. $UPB - MarketBeat
Lifesci Capital Predicts Upstream Bio FY2025 Earnings - Defense World
Upstream Bio: Maintaining Buy Rating On Verekitug Success In Phase 2 CRSwNP Study (UPB) - Seeking Alpha
UPB: Virectib's robust phase 2 results and unique mechanism set the stage for pivotal trials in 2026 - TradingView
Lifesci Capital Forecasts Upstream Bio FY2025 Earnings - MarketBeat
Upstream Bio (NASDAQ:UPB) Shares Down 8%Here's What Happened - MarketBeat
Finanzdaten der Upstream Bio Inc-Aktie (UPB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):